Novo valuation surpasses Tesla on experimental obesity drug data

Go back to Novo valuation surpasses Tesla on experimental obesity drug data
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1103.55 +4.98 (0.45%)
Previous Close $1098.57    52 Week High $88.16 
Open $1112.24    52 Week Low $67.88 
Day High $1119.45    P/E 255.45 
Day Low $1095.23    EPS $4.32 
Volume 505,248       

NOVO-NORDISK A/S (NYSE: NVO) Delayed: 45.71 +2.52 (5.83%)
Previous Close $43.19    52 Week High $59.00 
Open $44.01    52 Week Low $32.80 
Day High $45.72    P/E N/A 
Day Low $43.90    EPS $0.00 
Volume 5,052,141       

ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) Delayed: 32.67 +2.29 (7.54%)
Previous Close $30.38    52 Week High $5.17 
Open $30.52    52 Week Low $0.94 
Day High $32.90    P/E N/A 
Day Low $30.52    EPS $0.00 
Volume 1,034,015